Evaluation of the Effect of Glucagon Solutions on the Glucose Concentration at the Subcutaneous Administration Site in Type 1 Diabetic Patients.
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2015
Price : $35 *
At a glance
- Drugs Glucagon (Primary) ; Insulin; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 19 Dec 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 01 Aug 2014 New trial record